[HTML][HTML] Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi, LF Stefanelli… - Journal of Clinical …, 2023 - mdpi.com
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
[引用][C] Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi… - JOURNAL OF …, 2023 - research.unipd.it
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might
They Provide Additional Therapeutic Treatments? IRIS IRIS Home Sfoglia Macrotipologie & …
They Provide Additional Therapeutic Treatments? IRIS IRIS Home Sfoglia Macrotipologie & …
[HTML][HTML] Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi, LF Stefanelli… - Journal of Clinical …, 2023 - europepmc.org
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi… - Journal of Clinical …, 2023 - search.proquest.com
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi… - Journal of Clinical …, 2023 - search.ebscohost.com
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
G Bertoldi, I Caputo, G Driussi… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …
